SCHEMBL6420160

SCHEMBL6420160

FC(F)(F)COc1cc(-c2cccs2)n[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.61
CCNE2 O96020 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
SMPD3 Q9NY59 1/20 0.43
KDM4E B2RXH2 9/20 0.42
ALDH1A1 P00352 6/20 0.40
GAA P10253 3/20 0.40
ADORA2A P29274 1/20 0.39
SDHB P21912 2/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRA6 Q16445 1/20 0.39
L3MBTL1 Q9Y468 4/20 0.39
RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6414145 0.79 SMN1; SMN2 (0.48) SMN1; SMN2KDM4EALDH1A1GAAL3MBTL1
SCHEMBL5207573 0.76 SMN1; SMN2 (1.00) SMN1; SMN2CCNE2CCNE1CDK2KDM4E
SCHEMBL219145 0.71 ALDH1A1 (0.44) SMN1; SMN2KDM4EALDH1A1GAAL3MBTL1
SCHEMBL6414035 0.67 SMN1; SMN2 (0.58) SMN1; SMN2KDM4EALDH1A1GAAL3MBTL1
SCHEMBL1143192 0.67 SMN1; SMN2 (0.58) SMN1; SMN2CCNE2CCNE1CDK2KDM4E
SCHEMBL6412005 0.67 SMN1; SMN2 (0.58) SMN1; SMN2CCNE2CCNE1CDK2KDM4E
SCHEMBL624712 0.67 SMN1; SMN2 (0.54) SMN1; SMN2CCNE2CCNE1CDK2KDM4E
SCHEMBL14400727 0.67 SMN1; SMN2 (0.54) SMN1; SMN2KDM4EALDH1A1GAAADORA2A
SCHEMBL1074425 0.67 SMPD3 (0.38) SMN1; SMN2SMPD3KDM4EALDH1A1GAA
SCHEMBL24177588 0.65 KMT2A (0.46) SMPD3KDM4EALDH1A1L3MBTL1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050048092-A1 Thienyl-pyrazoles and their use for controlling pests WADA KATSUAKI (JP) 2005-03-03 US disclosed
US-6593358-B1 Method for controlling pests, comprising the step of allowing a pesticidally effective amount of one or more compounds selected from the group consisting of one or more compounds of the formula (Ia) according to claim 2 and one or compounds NIHON BAYER AGROCHEM K.K. (JP) 2003-07-15 US disclosed
EP-1200425-A1 THIENYL-PYRAZOLES AND THEIR USE FOR CONTROLLING PESTS NIHON BAYER AGROCHEM K.K. (JP) 2002-05-02 EP disclosed
WO-2001005787-A1 THIENYL-PYRAZOLES AND THEIR USE FOR CONTROLLING PESTS NIHON BAYER AGROCHEM K.K. (DE) 2001-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050048092-A1 Thienyl-pyrazoles and their use for controlling pests CBR3, C1S, CYP4B1 SMN1; SMN2 4328/4885CCNE2 666/4885CCNE1 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.